Seno Medical’s Next-Generation Imagio® Imaging System Obtains European Union (EU) Medical Device Regulation (MDR) CE Mark Certification
The CE Mark certification enables Seno Medical to market and sell the latest version of its Imagio® Imaging System with opto-acoustic, sound, and artificial intelligence in the European Union. Contact: Alex Hamlow, (210) 615-6501, ahamlow@senomedical.com [SAN ANTONIO, TX – 26-January-2026] Seno Medical has received CE Mark certification for its next-generation Imagio® Imaging System, Model 9100. […]
Emerging Imaging Technology Could Reduce Negative Exams and Biopsies for Patient
futureofpersonalhealth.com
Seno Medical® Receives Innovative Technology Contract from Vizient For its Imagio® Breast Imaging System
Contract awarded for products that bring improvement to healthcare industry [SAN ANTONIO, TX – November 12, 2024]– Seno Medical announced its Imagio® Breast Imaging System has received an Innovative Technology contract from Vizient, Inc. the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on the recommendation of the Imagio® System by […]
Real World Use of OA Imaging Confirms Clinical Acceptability of Second Generation Imagio® Breast Imaging System
[SAN ANTONIO, TX – October 31, 2024] A study published in Academic Radiology, Exploring the Utility of Optoacoustic Imaging in Differentiation of Benign and Malignant Breast Masses: Gen 2 Study, confirms that the second generation of Seno Medical’s Imagio® Breast Imaging System, which combines light, sound, and artificial intelligence (AI), is equal to or superior to the […]
IHE SHARAZONE Hits Major Milestone with 15 Participants, Empowering 37 Creators and 24 Consumers
[May 17, 2024] IHE-Europe is thrilled to report a major milestone for the IHE SHARAZONE, a groundbreaking initiative aimed at boosting digital interoperability and the exchange of health information. This innovative platform now proudly supports 15 participating organizations, each committed to enhancing the standardization of healthcare technologies, comprising 37 creators and 24 consumers systems with […]
IHE Sharazone hits major milestone
ihe-europe.net
American Medical Association Issues New CPT Code for Use of Seno Medical’s Opto-acoustic Technology in Breast Cancer Diagnosis
CPT Code 0857T Enables a Pathway for Reimbursement When Using Seno’s Imagio® Breast Imaging System to Diagnose Breast Cancer. [San Antonio, TX — February 13, 2024] The American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT*) code for the use of Imagio® (OA/US) Breast Imaging System, a new modality in breast cancer imaging and […]
Seno Medical Receives the 2023 Enabling Technology Leadership Award
Identified as best in class in USA opto-acoustic ultrasound imaging industy.
Seno Medical Earns Frost & Sullivan’s 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis with Its Cutting-edge Technology
Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer and significantly reduce unnecessary breast biopsies. San Antonio, TX — January 17, 2024 — Frost & Sullivan recently recognized Seno Medical with the 2023 US Enabling Technology Leadership Award. Seno Medical is a groundbreaking company founded in 2005 that revolutionized the breast cancer imaging sector with its innovative […]
Ultrasound plus opto-acoustic imaging for breast lesions: Five questions with Seno Medical
dotmed.com